About Kromek Group (LON:KMK)
Kromek Group plc designs, develops, and produces radiation detection products for applications within the medical, nuclear, and security screening markets worldwide. Its solutions provide high resolution information on material composition and structure to enable the identification of cancerous tissues and hazardous materials, including explosives, and the analysis of radioactive materials. It offers a portfolio of nuclear products for specific detection, identification, and quantification of radioactive materials in various applications, such as civil radiation detection, industrial process control, environmental monitoring, and personal detection use for the public. The company also provides detectors and subcomponents for OEM customers in the medical imaging market, including CT, SPECT, and Bone Mineral Densitometry, as well as colour imaging for the early detection of cancer, cardiac conditions, and osteoporosis with lower doses of radiation. In addition, it offers security screening products, such as D3S; 2D and 3D imaging equipment; Identifier for liquid explosive detection system; and liquid explosive detection algorithm for type c systems. Kromek Group plc was incorporated in 2003 and is headquartered in Sedgefield, the United Kingdom.
Industry, Sector and Symbol
Industry Medical Devices
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
EPS (Most Recent Fiscal Year)N/A
Return on Equity-5.54%
Return on Assets-4.74%
Kromek Group (LON:KMK) Frequently Asked Questions
What is Kromek Group's stock symbol?
Kromek Group trades on the London Stock Exchange (LON) under the ticker symbol "KMK."
How were Kromek Group's earnings last quarter?
Kromek Group PLC (LON:KMK) posted its quarterly earnings results on Tuesday, December, 19th. The company reported ($0.40) earnings per share for the quarter. The firm had revenue of $4.80 million for the quarter. Kromek Group had a negative return on equity of 5.54% and a negative net margin of 24.07%. View Kromek Group's Earnings History.
Who are some of Kromek Group's key competitors?
Some companies that are related to Kromek Group include REVA Medical (RVA), Medica Group (MGP), Ellex Medical Lasers (ELXMF), Creo Medical Group (CREO), Hamilton Thorne (HTL), Electromed (ELMD), Universal Biosensors (UBI), Advanced Oncotherapy (AVO), Protech Home Medical (PHM), MRI Interventions (MRIC), Surgical Innovations Group (SUN), NeuroOne Medical Tech (NMTC), PetVivo (PETV), Avacta Group (AVCT) and Myomo (MYO).
Who are Kromek Group's key executives?
Kromek Group's management team includes the folowing people:
- Dr. Arnab Basu MBE, CEO & Exec. Director (Age 45)
- Mr. Derek Bulmer, CFO, Company Sec. & Exec. Director (Age 52)
- Prof. Brian Keith Tanner MA, DPhil, CPhys, FInstP, FRSA, Advisor (Age 70)
- Prof. Max Robinson, Advisor (Age 73)
- Mr. Berry Beumer, Chief Operating Officer
Has Kromek Group been receiving favorable news coverage?
Media stories about KMK stock have been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern identifies positive and negative media coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Kromek Group earned a daily sentiment score of 0.03 on Accern's scale. They also gave news headlines about the company an impact score of 46.10 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company's share price in the near future.
How do I buy shares of Kromek Group?
Shares of KMK and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Kromek Group's stock price today?
One share of KMK stock can currently be purchased for approximately GBX 22.75.
How big of a company is Kromek Group?
Kromek Group has a market capitalization of £58.53 million.
How can I contact Kromek Group?
Kromek Group's mailing address is Netpark Incubator, Thomas Wright Way, STOCKTON-ON-TEES, TS21 3FD, United Kingdom. The company can be reached via phone at +44-1740-626060.
MarketBeat Community Rating for Kromek Group (KMK)MarketBeat's community ratings are surveys of what our community members think about Kromek Group and other stocks. Vote "Outperform" if you believe KMK will outperform the S&P 500 over the long term. Vote "Underperform" if you believe KMK will underperform the S&P 500 over the long term. You may vote once every thirty days.